Skip to main content
. 2021 Oct 4;17(4):356–362. doi: 10.4274/ejbh.galenos.2021.2021-4-8

Table 3. Comparison of disease-free and overall survival of luminal, node positive breast cancer patients undergoing conservative or radical breast and axillary treatment after neo-adjuvant chemotherapy.

graphic file with name ejbh-17-356-g5.jpg